AU Stock MarketDetailed Quotes

ZLD Zelira Therapeutics Ltd

Watchlist

0.490
0.0000.00%

20min DelayMarket Closed May 17 15:48 AET

5.56MMarket Cap-884P/E (Static)

Zelira Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

(FY)Jun 30, 2021

(Q4)Jun 30, 2021

(FY)Jun 30, 2020

(Q4)Jun 30, 2020

(FY)Jun 30, 2019

(Q4)Jun 30, 2019

Assets

Current assets

Cash, cash equivalents and short term investments

-94.68%146.21K

-44.75%2.75M

192.93%4.97M

-44.78%1.7M

-45.95%3.07M

-Cash and cash equivalents

-94.68%146.21K

-44.75%2.75M

192.93%4.97M

-44.78%1.7M

-45.95%3.07M

-Accounts receivable

-108.53%-8.65K

140.92%101.43K

--42.1K

----

Total current assets

-65.11%1.77M

-16.65%5.08M

232.30%6.09M

-41.34%1.83M

-45.91%3.12M

Non current assets

-Accumulated depreciation

-64.94%-412.66K

-65.17%-250.19K

-243.93%-151.47K

---44.04K

----

-Long term equity investment

-23.12%295.37K

-16.58%384.2K

-19.41%460.55K

--571.46K

----

-Goodwill

-0.49%31.56M

-0.49%31.71M

-0.49%31.87M

--32.03M

----

Regulatory assets

-100.43%-1.09K

346.51%256.45K

-10.45%57.43K

24.65%64.14K

-43.51%51.46K

Liabilities

Current liabilities

Current debt and capital lease obligation

22.12%142.53K

28.91%116.71K

48.75%90.53K

--60.86K

----

-Current capital lease obligation

22.12%142.53K

28.91%116.71K

48.75%90.53K

--60.86K

----

-accounts payable

15.30%1.74M

53.31%1.51M

76.08%984.98K

37.36%559.39K

309.60%407.24K

-Total tax payable

-23.12%295.37K

-16.58%384.2K

-19.41%460.55K

--571.46K

--0

Current liabilities

15.79%1.88M

51.25%1.63M

60.46%1.08M

64.59%670.25K

309.60%407.24K

Non current liabilities

-Long term debt

-23.12%295.37K

-16.58%384.2K

-19.41%460.55K

--571.46K

----

Non current accrued expenses

-38.80%518.75K

-31.58%847.63K

-21.59%1.24M

4,684.50%1.58M

--33.02K

Total non current liabilities

8.35%2.18M

30.92%2.01M

23.71%1.54M

204.91%1.24M

309.60%407.24K

Shareholders'equity

Share capital

4.05%45.52M

19.36%43.75M

40.56%36.65M

88.63%26.08M

0.00%13.82M

-common stock

4.05%45.52M

19.36%43.75M

40.56%36.65M

88.63%26.08M

0.00%13.82M

Gains losses not affecting retained earnings

1.31%31.05M

7.82%30.65M

4.62%28.43M

2,716.19%27.17M

91.96%964.82K

Total equity

-10.11%33.89M

-4.23%37.7M

9.99%39.37M

918.11%35.79M

-44.33%3.52M

	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(FY)Jun 30, 2022	(Q4)Jun 30, 2022	(FY)Jun 30, 2021	(Q4)Jun 30, 2021	(FY)Jun 30, 2020	(Q4)Jun 30, 2020	(FY)Jun 30, 2019	(Q4)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments	-94.68%146.21K	-94.68%146.21K	-44.75%2.75M	-44.75%2.75M	192.93%4.97M	192.93%4.97M	-44.78%1.7M	-44.78%1.7M	-45.95%3.07M	-45.95%3.07M
-Cash and cash equivalents	-94.68%146.21K	-94.68%146.21K	-44.75%2.75M	-44.75%2.75M	192.93%4.97M	192.93%4.97M	-44.78%1.7M	-44.78%1.7M	-45.95%3.07M	-45.95%3.07M
-Accounts receivable	-108.53%-8.65K	-108.53%-8.65K	140.92%101.43K	140.92%101.43K	--42.1K	--42.1K	----	----	----	----
Total current assets	-65.11%1.77M	-65.11%1.77M	-16.65%5.08M	-16.65%5.08M	232.30%6.09M	232.30%6.09M	-41.34%1.83M	-41.34%1.83M	-45.91%3.12M	-45.91%3.12M
Non current assets
-Accumulated depreciation	-64.94%-412.66K	-64.94%-412.66K	-65.17%-250.19K	-65.17%-250.19K	-243.93%-151.47K	-243.93%-151.47K	---44.04K	---44.04K	----	----
-Long term equity investment	-23.12%295.37K	-23.12%295.37K	-16.58%384.2K	-16.58%384.2K	-19.41%460.55K	-19.41%460.55K	--571.46K	--571.46K	----	----
-Goodwill	-0.49%31.56M	-0.49%31.56M	-0.49%31.71M	-0.49%31.71M	-0.49%31.87M	-0.49%31.87M	--32.03M	--32.03M	----	----
Regulatory assets	-100.43%-1.09K	-100.43%-1.09K	346.51%256.45K	346.51%256.45K	-10.45%57.43K	-10.45%57.43K	24.65%64.14K	24.65%64.14K	-43.51%51.46K	-43.51%51.46K
Liabilities
Current liabilities
Current debt and capital lease obligation	22.12%142.53K	22.12%142.53K	28.91%116.71K	28.91%116.71K	48.75%90.53K	48.75%90.53K	--60.86K	--60.86K	----	----
-Current capital lease obligation	22.12%142.53K	22.12%142.53K	28.91%116.71K	28.91%116.71K	48.75%90.53K	48.75%90.53K	--60.86K	--60.86K	----	----
-accounts payable	15.30%1.74M	15.30%1.74M	53.31%1.51M	53.31%1.51M	76.08%984.98K	76.08%984.98K	37.36%559.39K	37.36%559.39K	309.60%407.24K	309.60%407.24K
-Total tax payable	-23.12%295.37K	-23.12%295.37K	-16.58%384.2K	-16.58%384.2K	-19.41%460.55K	-19.41%460.55K	--571.46K	--571.46K	--0	--0
Current liabilities	15.79%1.88M	15.79%1.88M	51.25%1.63M	51.25%1.63M	60.46%1.08M	60.46%1.08M	64.59%670.25K	64.59%670.25K	309.60%407.24K	309.60%407.24K
Non current liabilities
-Long term debt	-23.12%295.37K	-23.12%295.37K	-16.58%384.2K	-16.58%384.2K	-19.41%460.55K	-19.41%460.55K	--571.46K	--571.46K	----	----
Non current accrued expenses	-38.80%518.75K	-38.80%518.75K	-31.58%847.63K	-31.58%847.63K	-21.59%1.24M	-21.59%1.24M	4,684.50%1.58M	4,684.50%1.58M	--33.02K	--33.02K
Total non current liabilities	8.35%2.18M	8.35%2.18M	30.92%2.01M	30.92%2.01M	23.71%1.54M	23.71%1.54M	204.91%1.24M	204.91%1.24M	309.60%407.24K	309.60%407.24K
Shareholders'equity
Share capital	4.05%45.52M	4.05%45.52M	19.36%43.75M	19.36%43.75M	40.56%36.65M	40.56%36.65M	88.63%26.08M	88.63%26.08M	0.00%13.82M	0.00%13.82M
-common stock	4.05%45.52M	4.05%45.52M	19.36%43.75M	19.36%43.75M	40.56%36.65M	40.56%36.65M	88.63%26.08M	88.63%26.08M	0.00%13.82M	0.00%13.82M
Gains losses not affecting retained earnings	1.31%31.05M	1.31%31.05M	7.82%30.65M	7.82%30.65M	4.62%28.43M	4.62%28.43M	2,716.19%27.17M	2,716.19%27.17M	91.96%964.82K	91.96%964.82K
Total equity	-10.11%33.89M	-10.11%33.89M	-4.23%37.7M	-4.23%37.7M	9.99%39.37M	9.99%39.37M	918.11%35.79M	918.11%35.79M	-44.33%3.52M	-44.33%3.52M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall